[Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
Ivanov
V T
VT
Institute of Bioorganic Chemistry of Shemiakin MM and Ovchinnikov IA, RAN.
Andronova
T M
TM
Nesmeianov
V A
VA
Pinegin
B V
BV
Ledger
P
P
Bomford
R
R
Khaitov
R M
RM
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D004341:Drug Evaluation; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy / Q000276:immunology; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D007239:Infections / Q000188:drug therapy / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C063429:glucosaminylmuramyl-2-alanine-D-isoglutamine